[HTML][HTML] Integrated Bioinformatics Investigation of Novel Biomarkers of Uterine Leiomyosarcoma Diagnosis and Outcome
A Rakic, R Anicic, M Rakic, L Nejkovic - Journal of Personalized Medicine, 2023 - mdpi.com
Uterine leiomyosarcomas (uLMS) have a poor prognosis and a high percentage of recurrent
disease. Bioinformatics has become an integral element in rare cancer studies by …
disease. Bioinformatics has become an integral element in rare cancer studies by …
Integrated Bioinformatics Investigation of Novel Biomarkers of Uterine Leiomyosarcoma Diagnosis and Outcome
A Rakic, R Anicic, M Rakic… - Journal of Personalized …, 2023 - search.proquest.com
Uterine leiomyosarcomas (uLMS) have a poor prognosis and a high percentage of recurrent
disease. Bioinformatics has become an integral element in rare cancer studies by …
disease. Bioinformatics has become an integral element in rare cancer studies by …
Integrated Bioinformatics Investigation of Novel Biomarkers of Uterine Leiomyosarcoma Diagnosis and Outcome
A Rakic, R Anicic, M Rakic… - Journal of personalized …, 2023 - pubmed.ncbi.nlm.nih.gov
Uterine leiomyosarcomas (uLMS) have a poor prognosis and a high percentage of recurrent
disease. Bioinformatics has become an integral element in rare cancer studies by …
disease. Bioinformatics has become an integral element in rare cancer studies by …
Integrated Bioinformatics Investigation of Novel Biomarkers of Uterine Leiomyosarcoma Diagnosis and Outcome.
A Rakic, R Anicic, M Rakic, L Nejkovic - Journal of Personalized …, 2023 - europepmc.org
Uterine leiomyosarcomas (uLMS) have a poor prognosis and a high percentage of recurrent
disease. Bioinformatics has become an integral element in rare cancer studies by …
disease. Bioinformatics has become an integral element in rare cancer studies by …
Integrated Bioinformatics Investigation of Novel Biomarkers of Uterine Leiomyosarcoma Diagnosis and Outcome.
A Rakic, R Anicic, M Rakic… - Journal of Personalized …, 2023 - search.ebscohost.com
Uterine leiomyosarcomas (uLMS) have a poor prognosis and a high percentage of recurrent
disease. Bioinformatics has become an integral element in rare cancer studies by …
disease. Bioinformatics has become an integral element in rare cancer studies by …
[HTML][HTML] Integrated Bioinformatics Investigation of Novel Biomarkers of Uterine Leiomyosarcoma Diagnosis and Outcome
A Rakic, R Anicic, M Rakic… - Journal of Personalized …, 2023 - ncbi.nlm.nih.gov
Uterine leiomyosarcomas (uLMS) have a poor prognosis and a high percentage of recurrent
disease. Bioinformatics has become an integral element in rare cancer studies by …
disease. Bioinformatics has become an integral element in rare cancer studies by …
Integrated Bioinformatics Investigation of Novel Biomarkers of Uterine Leiomyosarcoma Diagnosis and Outcome.
A Rakic, R Anicic, M Rakic, L Nejkovic - Journal of Personalized …, 2023 - europepmc.org
Uterine leiomyosarcomas (uLMS) have a poor prognosis and a high percentage of recurrent
disease. Bioinformatics has become an integral element in rare cancer studies by …
disease. Bioinformatics has become an integral element in rare cancer studies by …